Electric pulses zapping liver tumors: new hope for colorectal cancer patients?
NCT ID NCT07191548
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a procedure called irreversible electroporation (IRE), also known as Nanoknife, to treat liver tumors that have spread from colorectal cancer. IRE uses short electrical pulses to destroy cancer cells while sparing nearby blood vessels and bile ducts. The trial will enroll 50 adults who have already had chemotherapy and will measure how many tumors are completely gone after 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Irreversible electroporation (Nanoknife) - a procedure using electrical pulses to destroy cancer cells
What this could lead to
If successful, this could offer a new, targeted way to treat liver metastases from colorectal cancer without damaging nearby healthy tissue.
What could go wrong
This is an early-stage study with only 50 participants, so results may not apply to everyone. The procedure carries risks like bleeding or infection, and it may not fully eradicate all tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER ABLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Manchester Royal Infirmiary
Manchester, M13 9WL, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••